An Update on Aducanumab
Last month, we were pleased to share that the amyloid plaque targeted drug was being brought to a FDA advisory committee review. The drug was unfortunately not recommended for approval[…]
Last month, we were pleased to share that the amyloid plaque targeted drug was being brought to a FDA advisory committee review. The drug was unfortunately not recommended for approval[…]
The Wellness Initiative will begin a themed exploration of grief from January – June 2021. Following the insights in the newly released book, “Opening to Grief: Finding Your Way from Loss[…]